Pharma Reviews: Friday's Bull! Nifty Pharma soars 2.5% as new Covid variant takes focus - IndiaInfoline

... be said for Indian pharma stocks as the sector emerged as the only bull of today's trading session with broad-based buying across the counter.
Read more: Friday's Bull! Nifty Pharma soars 2.5% as new Covid variant takes focus - IndiaInfoline